Eight Patients are now Enrolled in the ImmuoSABR Clinical Trial
Our trial is steadily progressing and we now have eight patients in three centres enrolled in the ImmunoSABR trial .
First Patients Enrolled in ImmuoSABR Clinical Trial
Great news the first patients have been enrolled in the ImmunoSABRclinical Trial at NKI and AZM
METC Approval
METC approval received for the centres in Maastricht, Amsterdam and Nijmegen
Annual ImmunoSABR Meeting 2019
Partners Meeting held in Amsterdam reporting on the progress of the project.
New ImmunoSABR Website Launched
A new website has been designed to provide an overview of the ImmunoSABR project, its progress and information to the general public, patients and potential patients
Presentation – Brussels & Roma
Professor Philippe Lambin - Immunocytokines and Radiation at the Institut Bordet, Brussels. Unconventional immunotherapy and Radiation given in Roma at the yearly national course of radiation Oncology
Presentation – Paris
Professor Philippe Lambin given in Paris at the Immunorad meeting immunocytokines and radiation
Presentation – New York
Professor Philippe Lambin given in New York MSKCC on Immunocytokines and radiation
Presentation – Liverpool UK
Professor Philippe Lambin on Immunocytokines and Radiation given in Liverpool UK at UK Radiological Congress and Radiation and Oncology Congress (UKRCO)
Amendment EU, Periodic report, (Ready for) Submission
Protocol final, ICF and patient info final, Other documents for submission final, EU amendment Part A and B final, EU Technical Report part B final, CTA final and signed, Finalizing deliverables